Life threatened globally by rising multidrug-resistant infections or Antimicrobial Resistance (AMR). WCK 5222 administered on compassionate ground and saved 5 lives. Now in Global phase III clinical trial.
OUR DISCOVERY. ROAD TO RECOVERY.
Innovation Wins. Excellence Wins.
LIFE WINS
